This is to inform you that, in accordance with the provisions of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 read with AstraZeneca Pharma India Limited - Code of Conduct for Prevention of Insider Trading, the Trading Window for dealing in the Equity Shares of the Company will be closed from March 16, 2024 and the same shall reopen after 48 hours from the declaration of Audited Financial Results of the Company for the quarter and year ending March 31, 2024.